Global Human Microbiome Modulators Market Insights, Forecast to 2030

Publication ID:

PB512243023

Publication Date:

December 24, 2024

Pages:

108

Publisher:

MRRPB5

Countries:

Global [1]

USD 4,900.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The human microbiota is an aggregate of microorganisms residing in the human body, mostly in the gastrointestinal tract.
Market Analysis and Insights: Global Human Microbiome Modulators Market
The global Human Microbiome Modulators market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Human Microbiome Modulators is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Human Microbiome Modulators is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The Europe market for Human Microbiome Modulators is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The global key companies of Human Microbiome Modulators include Bayer, BioGaia, Chr. Hansen Holding, DowDuPont, Ingredion, ISOThrive, Jarrow Formulas, DSM and Lallemand, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Human Microbiome Modulators is widely used in various fields, such as Digestive Health, Immune Health, Oral Health and Others, etc. Digestive Health provides greatest supports to the Human Microbiome Modulators industry development. In 2023, global % revenue of Human Microbiome Modulators went into Digestive Health filed and the proportion will reach to % in 2030.
Report Covers:
This report presents an overview of global market for Human Microbiome Modulators market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Human Microbiome Modulators, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Human Microbiome Modulators, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Human Microbiome Modulators revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Human Microbiome Modulators market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Human Microbiome Modulators revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
Bayer
BioGaia
Chr. Hansen Holding
DowDuPont
Ingredion
ISOThrive
Jarrow Formulas
DSM
Lallemand
Sanofi
Segment by Type
Probiotics and Creams
Prebiotics and Dietary Supplements
Drugs
Segment by Application
Digestive Health
Immune Health
Oral Health
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Human Microbiome Modulators in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Human Microbiome Modulators companies鈥� competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Human Microbiome Modulators revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Human Microbiome Modulators Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Probiotics and Creams
1.2.3 Prebiotics and Dietary Supplements
1.2.4 Drugs
1.3 Market by Application
1.3.1 Global Human Microbiome Modulators Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Digestive Health
1.3.3 Immune Health
1.3.4 Oral Health
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Human Microbiome Modulators Market Perspective (2019-2030)
2.2 Global Human Microbiome Modulators Growth Trends by Region
2.2.1 Human Microbiome Modulators Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Human Microbiome Modulators Historic Market Size by Region (2019-2024)
2.2.3 Human Microbiome Modulators Forecasted Market Size by Region (2025-2030)
2.3 Human Microbiome Modulators Market Dynamics
2.3.1 Human Microbiome Modulators Industry Trends
2.3.2 Human Microbiome Modulators Market Drivers
2.3.3 Human Microbiome Modulators Market Challenges
2.3.4 Human Microbiome Modulators Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Human Microbiome Modulators by Players
3.1.1 Global Human Microbiome Modulators Revenue by Players (2019-2024)
3.1.2 Global Human Microbiome Modulators Revenue Market Share by Players (2019-2024)
3.2 Global Human Microbiome Modulators Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Human Microbiome Modulators, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Human Microbiome Modulators Market Concentration Ratio
3.4.1 Global Human Microbiome Modulators Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Human Microbiome Modulators Revenue in 2023
3.5 Global Key Players of Human Microbiome Modulators Head office and Area Served
3.6 Global Key Players of Human Microbiome Modulators, Product and Application
3.7 Global Key Players of Human Microbiome Modulators, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Human Microbiome Modulators Breakdown Data by Type
4.1 Global Human Microbiome Modulators Historic Market Size by Type (2019-2024)
4.2 Global Human Microbiome Modulators Forecasted Market Size by Type (2025-2030)
5 Human Microbiome Modulators Breakdown Data by Application
5.1 Global Human Microbiome Modulators Historic Market Size by Application (2019-2024)
5.2 Global Human Microbiome Modulators Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Human Microbiome Modulators Market Size (2019-2030)
6.2 North America Human Microbiome Modulators Market Size by Type
6.2.1 North America Human Microbiome Modulators Market Size by Type (2019-2024)
6.2.2 North America Human Microbiome Modulators Market Size by Type (2025-2030)
6.2.3 North America Human Microbiome Modulators Market Share by Type (2019-2030)
6.3 North America Human Microbiome Modulators Market Size by Application
6.3.1 North America Human Microbiome Modulators Market Size by Application (2019-2024)
6.3.2 North America Human Microbiome Modulators Market Size by Application (2025-2030)
6.3.3 North America Human Microbiome Modulators Market Share by Application (2019-2030)
6.4 North America Human Microbiome Modulators Market Size by Country
6.4.1 North America Human Microbiome Modulators Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Human Microbiome Modulators Market Size by Country (2019-2024)
6.4.3 North America Human Microbiome Modulators Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Human Microbiome Modulators Market Size (2019-2030)
7.2 Europe Human Microbiome Modulators Market Size by Type
7.2.1 Europe Human Microbiome Modulators Market Size by Type (2019-2024)
7.2.2 Europe Human Microbiome Modulators Market Size by Type (2025-2030)
7.2.3 Europe Human Microbiome Modulators Market Share by Type (2019-2030)
7.3 Europe Human Microbiome Modulators Market Size by Application
7.3.1 Europe Human Microbiome Modulators Market Size by Application (2019-2024)
7.3.2 Europe Human Microbiome Modulators Market Size by Application (2025-2030)
7.3.3 Europe Human Microbiome Modulators Market Share by Application (2019-2030)
7.4 Europe Human Microbiome Modulators Market Size by Country
7.4.1 Europe Human Microbiome Modulators Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Human Microbiome Modulators Market Size by Country (2019-2024)
7.4.3 Europe Human Microbiome Modulators Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Human Microbiome Modulators Market Size (2019-2030)
8.2 China Human Microbiome Modulators Market Size by Type
8.2.1 China Human Microbiome Modulators Market Size by Type (2019-2024)
8.2.2 China Human Microbiome Modulators Market Size by Type (2025-2030)
8.2.3 China Human Microbiome Modulators Market Share by Type (2019-2030)
8.3 China Human Microbiome Modulators Market Size by Application
8.3.1 China Human Microbiome Modulators Market Size by Application (2019-2024)
8.3.2 China Human Microbiome Modulators Market Size by Application (2025-2030)
8.3.3 China Human Microbiome Modulators Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Human Microbiome Modulators Market Size (2019-2030)
9.2 Asia Human Microbiome Modulators Market Size by Type
9.2.1 Asia Human Microbiome Modulators Market Size by Type (2019-2024)
9.2.2 Asia Human Microbiome Modulators Market Size by Type (2025-2030)
9.2.3 Asia Human Microbiome Modulators Market Share by Type (2019-2030)
9.3 Asia Human Microbiome Modulators Market Size by Application
9.3.1 Asia Human Microbiome Modulators Market Size by Application (2019-2024)
9.3.2 Asia Human Microbiome Modulators Market Size by Application (2025-2030)
9.3.3 Asia Human Microbiome Modulators Market Share by Application (2019-2030)
9.4 Asia Human Microbiome Modulators Market Size by Region
9.4.1 Asia Human Microbiome Modulators Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Human Microbiome Modulators Market Size by Region (2019-2024)
9.4.3 Asia Human Microbiome Modulators Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Human Microbiome Modulators Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Human Microbiome Modulators Market Size by Type
10.2.1 Middle East, Africa, and Latin America Human Microbiome Modulators Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Human Microbiome Modulators Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Human Microbiome Modulators Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Human Microbiome Modulators Market Size by Application
10.3.1 Middle East, Africa, and Latin America Human Microbiome Modulators Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Human Microbiome Modulators Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Human Microbiome Modulators Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Human Microbiome Modulators Market Size by Country
10.4.1 Middle East, Africa, and Latin America Human Microbiome Modulators Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Human Microbiome Modulators Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Human Microbiome Modulators Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Bayer
11.1.1 Bayer Company Details
11.1.2 Bayer Business Overview
11.1.3 Bayer Human Microbiome Modulators Introduction
11.1.4 Bayer Revenue in Human Microbiome Modulators Business (2019-2024)
11.1.5 Bayer Recent Developments
11.2 BioGaia
11.2.1 BioGaia Company Details
11.2.2 BioGaia Business Overview
11.2.3 BioGaia Human Microbiome Modulators Introduction
11.2.4 BioGaia Revenue in Human Microbiome Modulators Business (2019-2024)
11.2.5 BioGaia Recent Developments
11.3 Chr. Hansen Holding
11.3.1 Chr. Hansen Holding Company Details
11.3.2 Chr. Hansen Holding Business Overview
11.3.3 Chr. Hansen Holding Human Microbiome Modulators Introduction
11.3.4 Chr. Hansen Holding Revenue in Human Microbiome Modulators Business (2019-2024)
11.3.5 Chr. Hansen Holding Recent Developments
11.4 DowDuPont
11.4.1 DowDuPont Company Details
11.4.2 DowDuPont Business Overview
11.4.3 DowDuPont Human Microbiome Modulators Introduction
11.4.4 DowDuPont Revenue in Human Microbiome Modulators Business (2019-2024)
11.4.5 DowDuPont Recent Developments
11.5 Ingredion
11.5.1 Ingredion Company Details
11.5.2 Ingredion Business Overview
11.5.3 Ingredion Human Microbiome Modulators Introduction
11.5.4 Ingredion Revenue in Human Microbiome Modulators Business (2019-2024)
11.5.5 Ingredion Recent Developments
11.6 ISOThrive
11.6.1 ISOThrive Company Details
11.6.2 ISOThrive Business Overview
11.6.3 ISOThrive Human Microbiome Modulators Introduction
11.6.4 ISOThrive Revenue in Human Microbiome Modulators Business (2019-2024)
11.6.5 ISOThrive Recent Developments
11.7 Jarrow Formulas
11.7.1 Jarrow Formulas Company Details
11.7.2 Jarrow Formulas Business Overview
11.7.3 Jarrow Formulas Human Microbiome Modulators Introduction
11.7.4 Jarrow Formulas Revenue in Human Microbiome Modulators Business (2019-2024)
11.7.5 Jarrow Formulas Recent Developments
11.8 DSM
11.8.1 DSM Company Details
11.8.2 DSM Business Overview
11.8.3 DSM Human Microbiome Modulators Introduction
11.8.4 DSM Revenue in Human Microbiome Modulators Business (2019-2024)
11.8.5 DSM Recent Developments
11.9 Lallemand
11.9.1 Lallemand Company Details
11.9.2 Lallemand Business Overview
11.9.3 Lallemand Human Microbiome Modulators Introduction
11.9.4 Lallemand Revenue in Human Microbiome Modulators Business (2019-2024)
11.9.5 Lallemand Recent Developments
11.10 Sanofi
11.10.1 Sanofi Company Details
11.10.2 Sanofi Business Overview
11.10.3 Sanofi Human Microbiome Modulators Introduction
11.10.4 Sanofi Revenue in Human Microbiome Modulators Business (2019-2024)
11.10.5 Sanofi Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

Bayer
BioGaia
Chr. Hansen Holding
DowDuPont
Ingredion
ISOThrive
Jarrow Formulas
DSM
Lallemand
Sanofi

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂